Bicara Therapeutics Inc. Common Stock

Direct answer

Bicara Therapeutics Inc. Common Stock is publicly traded on NASDAQ under the ticker BCAX.

Bicara Therapeutics Inc., a biopharmaceutical firm in the clinical development phase, is headquartered in Boston, Massachusetts. Established in 2018, the company specializes in creating innovative, dual-action treatments specifically for solid tumors. At the forefront of their pipeline is ficerafusp alfa, a unique antibody designed to tackle solid cancers. This bifunctional therapeutic agent works by simultaneously...

Can you invest in Bicara Therapeutics Inc. Common Stock?

Yes. Bicara Therapeutics Inc. Common Stock is publicly traded on NASDAQ under the ticker BCAX.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Bicara Therapeutics Inc. Common Stock

Detailed equity research is provided by MarketSnap.